Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve The Company ....
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krebs Biochemicals & Industries has informed stock exchanges that its Board of Directors will meet on Thursday, 7 August 2025. The main agenda is to consider and adopt the unaudited financial results for the first quarter ended 30 June 2025. The filing was made under SEBI Listing Regulations (Regulation 29), which requires listed companies to give advance notice before considering financial results. The company also reminded that the trading window for insiders is already closed since 30 June 2025 and will reopen 48 hours after the Q1 results are declared.
This is a routine regulatory filing and not a major event. The actual Q1 results announcement on 7 August could move the stock depending on how the numbers compare with expectations. The closed trading window means insiders cannot trade until after results are published, which is standard practice.